952685-33-5

Usage

Type of drug

Nonsteroidal anti-inflammatory drug (NSAID)

Properties

Local anesthetic and analgesic

Uses

Relieving pain and inflammation in conditions such as sore throat, mouth ulcers, and dental pain

Mechanism of action

Inhibits the production of inflammatory chemicals in the body, reducing pain and swelling

Common forms

Lozenges, mouthwash, or spray for local application

Tolerability

Generally well-tolerated with minimal side effects such as mild irritation or burning sensation at the application site

Precautions

Should be used with caution in individuals with a history of allergies or asthma, and not recommended for use in children under 12 years of age.

Upstream product

• 569667-93-2 tert-butyl 3-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate 
• 591-51-5 phenyllithium 
• 100-58-3 phenylmagnesium bromide 

Downstream Products

• 25503-87-1 phenyl(pyrrolidin-3-yl)methanone hydrochloride 

Relevant academic research and scientific papers

3-(PHENOXYPHENYLMETHYL)PYRROLIDINE COMPOUNDS

In one aspect, the invention relates to compounds of formula I: where a and R1-6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors

AMIDE COMPOUNDS

The present invention provides compounds represented by the formula (Ie) and the formula (If) wherein each symbol is as defined in the specification. According to the present invention, these compounds have a DGAT inhibitory activity and are useful for the prophylaxis, treatment or improvement of diseases or pathologies caused by high expression or high activation of DGAT

DIAMINOPROPANOL RENIN INHIBITORS

Described are diaminopropanols of which are orally active and bind to renin to inhibit its activity. They are useful in the treatment or amelioration of diseases associated with elevated levels of renin activity or in the treatment of aspartic protease me